As a mage, I just want to pursue the truth

Chapter 99 Immature Science and Creation Creatures (please subscribe!)

This is not the first time Li Miaomiao has come to England. He has been to Cambridge and Oxford during his high school holidays.

The feeling of coming to England this time is different from the last time. This time I came with a goal. Kechuangbio will acquire an AI chip company in England and build an AI chip research and development center in England based on this.

Secondmind is only the first goal of Kechuangbio, and there are several other companies as candidates.

This is also the first time to go abroad after the spread of the global epidemic. Li Miaomiao took a deep breath after getting off the plane, wearing N95 on the plane and almost suffocating hypoxia.

"Everyone go through the prepared materials again after arriving at the hotel today, so that there will be no mistakes tomorrow."

Li Miaomiao specially asked her to take charge of this trip to England, because she wanted to pass through the Lion City on the way back to see Zheng Li.

"We are a biomedical company in Huaguo, and we hope to acquire your company. We will not interfere with the normal operation of the company for the first three years after we acquire the company."

The reason why Goose Factory is more popular than Ari in the investment world is that Goose Factory seldom interferes with the operation of its investment companies, while Ari likes to participate in the operation of investment companies, replacing the executives of its investment companies with Ari. employees.

In the investment circle, Ali is more domineering than Goose Factory.

"We will only give you opinions on AI chips and algorithms."

"Employee and executive treatment will also remain the same."

"This is the information of Kechuangbiology, you can take a look."

As the global leader in the field of brain-computer connection, Kechuangbio is still well-known.

Although the specific company name may not be uttered, when it comes to the company in Huaguo that specializes in brain-computer connections to mobile phones and endorphins, foreigners can understand it in seconds.

Endorphins are as well-known in the field of biomedicine as brain-computer connections.

After the simultaneous interpreter translated Li Miaomiao's words, the chairman of secondmind nodded: "Okay, let me take a look first."

The conference room was silent, save for the rustling of pages turning.

"I don't deny that Kechuang Bio is an outstanding company with unique contributions in its own field."

"But we are very curious, why Kechuangbio would want to acquire secondmind? According to the company's information, there is no overlap in our fields of business."

"SecondMind is mainly engaged in AI algorithms and AI chips related to autonomous driving, while Kechuang Biology seems to be brain-computer connection in addition to biomedicine."

"Your company acquired us, and I feel that there is very little overlap and complementarity."

"So why should we accept your offer?"

Regarding the embarrassment of the other party, Li Miaomiao was very calm:

"Secondmind has not received new investment since its B-round investment in 19, and the valuation of secondmind's B-round investment in 19 was 1 million yuan, but the actual funds raised were only 2400 million yuan."

"Affected by the epidemic in the past two years, the price of chip foundry has been rising year by year, and labor costs are also rising. I wonder how long secondmind can last without investment?"

"As an AI chip company in England, Graphcore received a large amount of funding last year, and deepmind has been backed by Google since 14."

"How does secondmind survive? The cooperation with Mazda has limited revenue, so it should not be able to support the company's further development."

England is an important place for AI research. Over the years, multinational giants have continued to invest in AI companies in England, but there are few Chinese companies.

HP announced the acquisition of Autonomy.Amazon acquired True Knowledge; in 2014, Google acquired deepmind, Dark Blue Labs, and Vision Factory, Apple acquired VocalIQ, Microsoft acquired SwiftKey, and Twitter acquired MagicPony.

The latter are all enterprises in the field of artificial intelligence in England, not all AI chips.

"Our funds are sufficient, and other investment institutions have expressed their willingness to participate in secondmind's C round of investment."

"We will promote secondmind's C-round fundraising soon, and giants like Kechuang Bio are very welcome to participate."

They welcome investment, but don't want to be acquired.

Li Miaomiao was very skeptical in her heart. No one continued to invest in you for the past two years. As soon as we said we wanted to buy, someone came to invest?
After thinking about it, Cheng Gang told him when she was on the road that Goldman Sachs and IDG also wanted to participate in the investment of secondmind.

"Did IDG and Goldman Sachs want to invest in you?"

The other party nodded: "Since you know, then I have nothing to hide."

"IDG and Goldman Sachs have signed share transfer memorandums with our shareholders respectively, and the two investment institutions expressed that they will help us start the C round of fundraising as soon as possible."

"IDG and Goldman Sachs will lead the round."

Li Miaomiao thought that these investment institutions were really shameless, knowing that Kechuang Biology was going to acquire SecondMind and then making a move more decisively than them.

In this regard, Kechuang Bio still has many deficiencies. If it were replaced by a goose factory, this matter would have been completed without anyone noticing.

The first meeting ended in a hurry, and Li Miaomiao felt that she needed to review the specific situation of this matter.

Then figure out the intentions of IDG and Goldman Sachs.

At present, the only shareholders of secondmind are Goldman Sachs, IDG, Goose Factory, Cambridge University Investment Fund and founders.

The shareholding structure is simple, but there isn't a fuel-efficient lamp inside.

Kechuangbiology issued an announcement at midnight on New Year's Day. The content of the announcement is roughly as follows:

"Kechuangbiology has completed the research and development of brain-computer connected mobile phone English-speaking all races, the patent is being registered globally, and the patent licensing negotiations have been carried out simultaneously with major mobile phone manufacturers."

It also explained that the price of English-based brain-computer connection patent authorization needs to be adjusted, and it will not be [-] yuan per mobile phone like the Chinese-based patent authorization.

As soon as the news came out, the top ten sci-tech biological stocks were quickly pushed to the first place:
"Good landing, high diving!"

There are many such remarks. Not only is there some truth to high-level diving, but also people in the stock market have a mentality.

"The current price of Kechuang Biology is only more than 2000 yuan, which is not high, and it is expected to reach 3000 yuan in the short term."

At present, Kechuang Biology and Moutai are the only two companies with a unit price of more than 2000 yuan in the A-share market.

Liquor companies have been rising so much that stockholders joked that Huaguo's technology stocks are Jiangxiang Technology and Luxiang Technology.

Most investors are still happy to see technology stocks represent Huaguo's stock exchange market rather than wine companies.

"The patent authorization of English-based brain-computer connection to mobile phones can release at least 2022 billion RMB in profits for Kechuangbiology in 60, which is calculated based on the current patent authorization price.

If the price is renegotiated, the net profit will increase.

Profit is not the most important thing, but what is more important is that Kechuang Biotech was the first to issue an announcement, indicating that it is still the strongest company in the field of brain-computer connection.

Kechuang Bio's revenue in the field of brain-computer connection is the sum of the revenue of all other companies in the field of brain-computer connection.

Such a company with core monopoly technology, and maintains high growth and high profits, why not open a position? "

　Tomorrow at twelve o'clock, I'll take a look and add a few more~ Today the author has a low fever, and I will update it for everyone, I belong to the severely handicapped party, and I don't like to keep manuscripts.So I hope everyone will give a first order for the sake of the author's sick update!I went to bed and got up tomorrow to watch the first order~
　　
　
(End of this chapter)